|38.97||+0.90 / +2.36%|
Data as of 4:00pm ET
|38.97||+0.0047 / +0.01%|
The 2 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 50.50, with a high estimate of 55.00 and a low estimate of 46.00. The median estimate represents a +29.59% increase from the last price of 38.97.
The current consensus among 2 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.